Mukka Proteins Limited (IN:MUKKA)
:MUKKA
Want to see IN:MUKKA full AI Analyst Report?
MUKKA Stock Chart & Stats
₹23.74
₹0.02(0.05%)
At close: 4:00 PM EST
₹23.74
₹0.02(0.05%)
Day’s Range― - ―
52-Week Range₹18.32 - ₹32.81
Previous CloseN/A
Volume628.76K
Average Volume (3M)40.24K
Market Cap
₹7.29B
Enterprise Value₹12.82B
Total Cash (Recent Filing)₹30.75M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)7.6
Beta0.77
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.79
Shares Outstanding300,000,000
10 Day Avg. Volume18,929
30 Day Avg. Volume40,240
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)2.25
Price to Sales (P/S)0.98
P/FCF Ratio-7.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained double‑digit revenue growth reflects rising demand for fish‑based feed ingredients and expanding processing volumes. A durable top‑line trajectory supports scale benefits and fixed‑cost absorption, positioning the company to invest in capacity or margin improvement if sustained.
Gross Margin / Production EfficiencyA gross margin above 23% signals efficient processing and favorable product spreads versus raw material costs. Persistent manufacturing efficiency supports margin resilience through commodity cycles, enabling the firm to protect operating profitability and long‑term cash generation potential.
Equity Base And ROEAn increasing equity base alongside a commendable ROE suggests effective reinvestment of earnings and competent capital allocation. This structural strength supports internal funding capacity for expansion and indicates management has historically generated acceptable returns on shareholder capital.
Bears Say
High LeverageElevated leverage reduces financial flexibility and increases refinancing and interest burden risk. In a cyclical commodity business, high debt amplifies earnings volatility and can constrain capex, working capital and strategic investments during downturns, raising structural risk over months.
Negative Operating Cash FlowPersistent negative operating and free cash flow undermines self‑funding ability and raises dependence on external financing. Over a multi‑month horizon this heightens liquidity risk, limits capacity to deleverage or invest, and stresses cash management in a working‑capital intensive supply chain.
Declining Net Income / EPSA meaningful EPS decline and noted drop in net profit margin point to cost pressures or weaker realizations, eroding earnings quality. If margin compression continues, converting revenue growth into durable profitability and cash flow will be more difficult, pressuring long‑term returns.
Mukka Proteins Limited News
MUKKA FAQ
What was Mukka Proteins Limited’s price range in the past 12 months?
Mukka Proteins Limited lowest stock price was ₹18.32 and its highest was ₹32.81 in the past 12 months.
What is Mukka Proteins Limited’s market cap?
Mukka Proteins Limited’s market cap is ₹7.29B.
When is Mukka Proteins Limited’s upcoming earnings report date?
Mukka Proteins Limited’s upcoming earnings report date is May 20, 2026 which is in 21 days.
How were Mukka Proteins Limited’s earnings last quarter?
Mukka Proteins Limited released its earnings results on Feb 12, 2026. The company reported ₹0.792 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.792.
Is Mukka Proteins Limited overvalued?
According to Wall Street analysts Mukka Proteins Limited’s price is currently Overvalued.
Does Mukka Proteins Limited pay dividends?
Mukka Proteins Limited does not currently pay dividends.
What is Mukka Proteins Limited’s EPS estimate?
Mukka Proteins Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mukka Proteins Limited have?
Mukka Proteins Limited has 300,000,000 shares outstanding.
What happened to Mukka Proteins Limited’s price movement after its last earnings report?
Mukka Proteins Limited reported an EPS of ₹0.792 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.417%.
Which hedge fund is a major shareholder of Mukka Proteins Limited?
Currently, no hedge funds are holding shares in IN:MUKKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mukka Proteins Limited
Mukka Proteins Limited manufactures and sells fish protein products in India. It offers fish meal, oil, and soluble paste. The company also offers insect meal and insect oil. The company's products are used as an ingredient for animal feed, poultry feed, aquaculture feed, pharmaceutical products, soap manufacture, leather tanneries, and paint industries. It also exports its products to Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam. Mukka Proteins Limited was formerly known as Mukka Sea Food Industries Limited and changed its name to Mukka Proteins Limited in August 2021. The company was founded in 1960 and is based in Mangaluru, India.
Technical Analysis
Gokul Refoils & Solvent Ltd.
―
Goodricke Group Ltd
―
Kothari Products Limited.
―
Sanwaria Consumer Ltd
―
Shree Ram Proteins Ltd.
―